TY - JOUR
T1 - Bioprocess intensification
T2 - Cases that (don't) work
AU - van der Wielen, Luuk A.M.
AU - Mussatto, Solange I.
AU - van Breugel, Jan
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2021/3/25
Y1 - 2021/3/25
N2 - Development of affordable and low carbon biobased manufacturing depends critically on strategies that reduce cost and emission profiles. This paper indicates that efforts around the reduction of capital costs by intensification of process equipment need to be carefully weighed against the inherently fast increasing financial and climate costs of driving forces used for the intensification. The fundamental relation between capital expenditures (CAPEX) and operational expenditures (OPEX) of intensified and non-intensified biobased processes and their financial and climatic impacts are emphasized and provisionally explored for a few industrial processes. General learnings flag the importance in particular of OPEX minimisation for sustainable bio-economic development.
AB - Development of affordable and low carbon biobased manufacturing depends critically on strategies that reduce cost and emission profiles. This paper indicates that efforts around the reduction of capital costs by intensification of process equipment need to be carefully weighed against the inherently fast increasing financial and climate costs of driving forces used for the intensification. The fundamental relation between capital expenditures (CAPEX) and operational expenditures (OPEX) of intensified and non-intensified biobased processes and their financial and climatic impacts are emphasized and provisionally explored for a few industrial processes. General learnings flag the importance in particular of OPEX minimisation for sustainable bio-economic development.
KW - Bioprocess intensification
KW - Integrated biobased manufacturing
KW - Techno-Economic assessment
KW - Thermodynamic analysis
UR - http://www.scopus.com/inward/record.url?scp=85097522801&partnerID=8YFLogxK
U2 - 10.1016/j.nbt.2020.11.007
DO - 10.1016/j.nbt.2020.11.007
M3 - Article
C2 - 33221394
AN - SCOPUS:85097522801
SN - 1871-6784
VL - 61
SP - 108
EP - 115
JO - New Biotechnology
JF - New Biotechnology
ER -